| Device |
direct blood bacterial nucleic acid detection system |
| Regulation Description |
Nucleic acid-based device for the amplification, detection, and identification of microbial pathogens directly from whole blood specimens. |
| Definition |
Amplification, detection and identification of microbial pathogens directly from whole blood specimens |
| Physical State |
The direct blood bacterial nucleic acid detection system consists of reagents and disposables. The associated instrumentation performs the amplification of bacterial nucleic acid, detects the amplified products and reports results. |
| Technical Method |
A multiplexed nucleic acid amplification assay that amplifies and detects bacterial DNA in whole blood specimens |
| Target Area |
Nucleic acids of bacteria |
| Regulation Medical Specialty |
Microbiology |
| Review Panel |
Microbiology |
| Product Code | QBX |
| Premarket Review |
Office of In Vitro Diagnostics
(OHT7)
Division of Microbiology Devices
(DMD)
|
| Submission Type |
510(k)
|
| Regulation Number |
866.3960
|
| Device Class |
2
|
| Total Product Life Cycle (TPLC) |
TPLC Product Code Report
|
| GMP Exempt? |
No
|
Summary Malfunction Reporting |
Ineligible |
| Implanted Device? |
No
|
| Life-Sustain/Support Device? |
No
|
| Third Party Review |
Not Third Party Eligible |